Titlebook: Early Gastrointestinal Cancers; Florian Otto,Manfred P. Lutz Conference proceedings 2012 Springer-Verlag Berlin Heidelberg 2012 Chemothera

metropolitan

senile-dementia

受辱

Choosing the Best Treatment for Esophageal Cancerereas neoadjuvant chemotherapy is only appropriate for patients with adenocarcinoma. However, the 2-year survival benefit by this induction therapy compared to surgery alone is only 5–9 %. Targeted drugs seem to be promising in order to improve the response rate. The choice of the best multimodal th

regale

bronchodilator

Radiotherapy of Gastroesophageal Junction CancerWhile early T1/2 N0 tumors are treated with surgery alone, they are only found in a small subset of patients due to the lack of symptoms at this stage. Most of the tumors are detected in locally advanced stage where surgery alone results in disappointing outcome. Chemotherapy and/or chemoirradiation

immunity

antiquated

Early Gastrointestinal Cancers978-3-642-31629-6Series ISSN 0080-0015 Series E-ISSN 2197-6767

洞察力

Enliven

978-3-642-44161-5Springer-Verlag Berlin Heidelberg 2012

manifestation